Valuation: Virbac SA

Market Cap 2.76B 3.22B 2.58B 2.37B 4.45B 308B 4.53B 30.46B 11.93B 155B 12.1B 11.84B 511B P/E 2026 *
16.2x
P/E 2027 * 14.6x
Enterprise Value 2.89B 3.37B 2.7B 2.48B 4.66B 322B 4.73B 31.86B 12.48B 162B 12.66B 12.38B 534B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.72x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.2B
+4.39%+5.06%-50.37%-57.27% 30.56B
+3.24%+10.12%+39.10%+108.47% 11.81B
-2.19%0.00%-17.85%+5.74% 3.95B
+0.15%-0.90%-1.93%+24.95% 3.2B
-2.52%-4.09%+47.53%+37.20% 2.18B
+0.86%+0.43%+12.26%+17.74% 1.94B
+2.97%+5.33%+11.77%+137.97% 1.41B
-2.28%+1.60%-19.96%+4.19% 1.27B
-1.91%+1.06%-11.76%-42.95% 1.03B
Average +0.26%-0.85%+0.98%+26.23% 6.37B
Weighted average by Cap. +2.76%-0.45%-18.27%-1.68%

Financials

2026 *2027 *
Net sales 1.55B 1.81B 1.45B 1.33B 2.5B 173B 2.54B 17.09B 6.69B 86.67B 6.79B 6.64B 287B 1.65B 1.92B 1.54B 1.41B 2.65B 184B 2.7B 18.15B 7.11B 92.06B 7.21B 7.05B 304B
Net income 171M 199M 160M 147M 276M 19.07B 280M 1.89B 738M 9.56B 749M 733M 31.62B 190M 221M 177M 162M 305M 21.12B 310M 2.09B 818M 10.59B 830M 812M 35.02B
Net Debt 127M 148M 118M 109M 204M 14.12B 208M 1.4B 547M 7.08B 555M 543M 23.42B 75.16M 87.62M 70.18M 64.39M 121M 8.37B 123M 828M 324M 4.2B 329M 322M 13.89B
Logo Virbac SA
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
330.00EUR
Average target price
411.88EUR
Spread / Average Target
+24.81%

Quarterly revenue - Rate of surprise